Squarepoint
MED icon

Squarepoint’s Medifast MED Stock Holding History

Squarepoint’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$214K Buy
+20,140
New +$232K ﹤0.01% 4028
2024
Q3 		– Sell
-23,976
Closed -$523K – 4468
2024
Q2 		$523K Buy
+23,976
New +$639K ﹤0.01% 3040
2023
Q1 		– Sell
-7,034
Closed -$811K – 3554
2022
Q4 		$811K Sell
7,034
-1,923
-21% -$224K ﹤0.01% 1971
2022
Q3 		$971K Buy
+8,957
New +$1.28M ﹤0.01% 1797
2022
Q2 		– Sell
-3,397
Closed -$580K – 3178
2022
Q1 		$580K Buy
3,397
+133
+4% +$25.1K ﹤0.01% 1922
2021
Q4 		$684K Sell
3,264
-2,158
-40% -$446K ﹤0.01% 1937
2021
Q3 		$1.04M Sell
5,422
-22,892
-81% -$5.63M ﹤0.01% 1544
2021
Q2 		$8.01M Sell
28,314
-8,011
-22% -$2.17M 0.03% 540
2021
Q1 		$7.69M Buy
36,325
+17,089
+89% +$4.09M 0.05% 453
2020
Q4 		$3.78M Buy
19,236
+1,595
+9% +$282K 0.03% 609
2020
Q3 		$2.9M Sell
17,641
-423
-2% -$69.6K 0.04% 522
2020
Q2 		$2.51M Sell
18,064
-28,145
-61% -$2.58M 0.04% 556
2020
Q1 		$2.89M Sell
46,209
-12,466
-21% -$1.13M 0.07% 347
2019
Q4 		$6.43M Sell
58,675
-32,880
-36% -$3.18M 0.04% 422
2019
Q3 		$9.49M Buy
91,555
+48,983
+115% +$5.26M 0.08% 298
2019
Q2 		$5.46M Sell
42,572
-31,955
-43% -$4.44M 0.05% 415
2019
Q1 		$9.51M Buy
74,527
+37,392
+101% +$4.74M 0.1% 247
2018
Q4 		$4.64M Sell
37,135
-283
-0.8% -$48.4K 0.05% 426
2018
Q3 		$8.29M Buy
37,418
+22,602
+153% +$4.58M 0.1% 271
2018
Q2 		$2.37M Sell
14,816
-9,730
-40% -$1.24M 0.03% 580
2018
Q1 		$2.29M Buy
24,546
+20,948
+582% +$1.57M 0.04% 520
2017
Q4 		$251K Sell
3,598
-842
-19% -$55.9K ﹤0.01% 1642
2017
Q3 		$264K Buy
+4,440
New +$221K 0.01% 1237
2017
Q1 		– Sell
-4,927
Closed -$205K – 1747
2016
Q4 		$205K Buy
+4,927
New +$198K 0.01% 1427

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Squarepoint's MED Position: Q2 2026 in Review

Squarepoint opened a new position in Medifast (MED) in Q2 2026: 20,140 shares worth $214K. The stake represents ﹤0.01% of the portfolio and ranks #4028 among its holdings. This is a return to the name: Squarepoint previously reported a position in MED as recently as Q2 2024.

Squarepoint first reported a position in MED in Q4 2016 and has held it in 24 quarters since. The position peaked at $9.51M in Q1 2019. 113 funds tracked by Wall St. Rank hold MED as of Q2 2026.

  • Squarepoint held 20,140 shares of Medifast worth $214K as of Q2 2026.
  • Medifast was a new Squarepoint position in Q2 2026.
  • Medifast made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #4028 holding.
  • Squarepoint first reported a position in Medifast in Q4 2016 and has held it in 24 quarters since.
  • Squarepoint's Medifast position peaked at $9.51M in Q1 2019.
  • 113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.